SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
作者： CLAUS G. ROEHRBORN , JOHN McCONNELL , JAIME BONILLA , SIDNEY ROSENBLATT , PERRY B. HUDSON
DOI: 10.1016/S0022-5347(05)67962-1
关键词:
摘要: Purpose: We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated placebo during 4 years, determine which baseline parameters were the st...
jurology.com 参考文章(24)
Michael J. Barry, Abraham T.K. Cockett, H. Logan Holtgrewe, John D. McConnell, Stephen A. Sihelnik, Howard N. Winfield, Relationship of Symptoms of Prostatism to Commonly Used Physiological and Anatomical Measures of the Severity of Benign Prostatic Hyperplasia The Journal of Urology. ,vol. 150, pp. 351- 358 ,(1993) , 10.1016/S0022-5347(17)35482-4
Michael B. Chancellor, Jerry G. Blaivas, Steven A. Kaplan, Sheldon Axelrod, Bladder Outlet Obstruction versus Impaired Detrusor Contractility: The Role of Uroflow Journal of Urology. ,vol. 145, pp. 810- 812 ,(1991) , 10.1016/S0022-5347(17)38458-6
M M Elhilali, S K Afridi, J C Nickel, J P Perreault, P J Pommerville, R C Boake, Y Fradet, Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study Canadian Medical Association Journal. ,vol. 155, pp. 1251- 1259 ,(1996)
Jaime Bonilla, Elizabeth Stoner, Placido Grino, Bruce Binkowitz, Alice Taylor, Intra‐ and interobserver variability of MRI prostate volume measurements The Prostate. ,vol. 31, pp. 98- 102 ,(1997) , 10.1002/(SICI)1097-0045(19970501)31:2<98::AID-PROS4>3.0.CO;2-D
Peter Boyle, A. Lawrence Gould, Claus G. Roehrborn, Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials* Urology. ,vol. 48, pp. 398- 405 ,(1996) , 10.1016/S0090-4295(96)00353-6
H. A. Guess, H. M. Arrighi, E. J. Metter, J. L. Fozard, Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. The Prostate. ,vol. 17, pp. 241- 246 ,(1990) , 10.1002/PROS.2990170308
Steven J. Jacobsen, Debra J. Jacobson, Cynthia J. Girman, Rosebud O. Roberts, Thomas Rhodes, Harry A. Guess, Michael M. Lieber, Natural History of Prostatism: Risk Factors for Acute Urinary Retention Journal of Urology. ,vol. 158, pp. 481- 487 ,(1997) , 10.1016/S0022-5347(01)64508-7
Claus G Roehrborn, John D McConnell, Michael Lieber, Steven Kaplan, Jack Geller, Gholem H Malek, Ronald Castellanos, Scott Coffield, Brian Saltzman, Martin Resnick, Thomas J Cook, Joanne Waldstreicher, PLESS Study Group, Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia Urology. ,vol. 53, pp. 473- 480 ,(1999) , 10.1016/S0090-4295(98)00654-2
Steven A. Kaplan, Alexis E. Te, Lee B. Pressler, Carl A. Olsson, Transition Zone Index as a Method of Assessing Benign Prostatic Hyperplasia: Correlation with Symptoms, Urine Flow and Detrusor Pressure The Journal of Urology. ,vol. 154, pp. 1764- 1769 ,(1995) , 10.1016/S0022-5347(01)66779-X
Claus G Roehrborn, Joseph E Oesterling, Stephen Auerbach, Stephen A Kaplan, L Keith Lloyd, Douglas F Milam, Robert J Padley, HYCAT Investigator Group, The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia Urology. ,vol. 47, pp. 159- 168 ,(1996) , 10.1016/S0090-4295(99)80409-9